Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma.

Trial Profile

Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma.

Completed
Phase of Trial: Phase I

Latest Information Update: 19 Jan 2012

At a glance

  • Drugs Imatinib (Primary)
  • Indications Malignant thymoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 19 Jan 2012 Actual patient number (11) added as reported by ClinicalTrials.gov.
    • 19 Jan 2012 Actual end date (1 Mar 2011 ) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top